Use of nanoparticles in cell tracing in advanced therapies: possibilities and challenges for clinical application
Autor(a) principal: | |
---|---|
Data de Publicação: | 2018 |
Outros Autores: | |
Tipo de documento: | Artigo |
Idioma: | por eng |
Título da fonte: | Vigilância Sanitária em Debate |
Texto Completo: | https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1067 |
Resumo: | Introduction: Regulation and introduction of new advanced cellular technologies in clinics requires better knowledge on the used cells. One of the major challenges is the difficulty to accurately determine the mechanisms of cell activities when submitted to advanced therapies. Objective: Understand, using the cell tracking methods, the tissue distribution and the molecular response of cells exposed to advanced therapies. Methods: This work was done as an integrated review of data collected in international data-bases and of legislations concerning the clinical use of nanoparticles. Results: Nanotechnology is a very useful tool for cell tracking in vivo, and several nanoparticles have been already approved for clinical use; they can be incorporated into cells and visualized by magnetic resonance imaging. Conclusions: The perspectives on the use of nanomedicines for cellular tracking in medical clinic are promising, requiring elaboration and approval of laws, guides and norms to orient the industrial sectors, regarding the nanomaterials characterization and potential risks to human and animal health, as well as to the environment. |
id |
FIOCRUZ-9_566ce6282453ea1c809193ddba9504f6 |
---|---|
oai_identifier_str |
oai:ojs.visaemdebate.incqs.fiocruz.br:article/1067 |
network_acronym_str |
FIOCRUZ-9 |
network_name_str |
Vigilância Sanitária em Debate |
repository_id_str |
|
spelling |
Use of nanoparticles in cell tracing in advanced therapies: possibilities and challenges for clinical applicationUso de nanopartículas no rastreamento de células em terapias avançadas: possibilidades e desafios para a aplicação clínicaMagnetic NanoparticlesCell TackingStem CellsAdvanced TherapiesNanomedicineNanopartículas MagnéticasRastreamento CelularCélulas-troncoTerapias AvançadasNanomedicamentosIntroduction: Regulation and introduction of new advanced cellular technologies in clinics requires better knowledge on the used cells. One of the major challenges is the difficulty to accurately determine the mechanisms of cell activities when submitted to advanced therapies. Objective: Understand, using the cell tracking methods, the tissue distribution and the molecular response of cells exposed to advanced therapies. Methods: This work was done as an integrated review of data collected in international data-bases and of legislations concerning the clinical use of nanoparticles. Results: Nanotechnology is a very useful tool for cell tracking in vivo, and several nanoparticles have been already approved for clinical use; they can be incorporated into cells and visualized by magnetic resonance imaging. Conclusions: The perspectives on the use of nanomedicines for cellular tracking in medical clinic are promising, requiring elaboration and approval of laws, guides and norms to orient the industrial sectors, regarding the nanomaterials characterization and potential risks to human and animal health, as well as to the environment.Introdução: Para uma regulamentação específica e implementação das novas tecnologias avançadas na clínica médica, é preciso refinar o conhecimento sobre as células utilizadas. Um dos maiores desafios está na dificuldade em determinar os mecanismos de funcionamento das células após a terapia. Objetivo: Compreender, usando os métodos de rastreamento celular em pacientes, a distribuição e a função de células usadas em terapias avançadas. Método: Este trabalho foi elaborado pelo levantamento de artigos científicos nas bases de dados internacionais e da legislação vigente sobre a utilização clínica das nanopartículas. Resultados: Constatamos que a nanotecnologia já é uma ferramenta de grande utilidade, pois diversas nanopartículas magnéticas já são aprovadas para uso clínico; elas podem ser incorporadas por células e visualizadas por imagens de ressonância magnética. O presente texto discute as perspectivas sobre uso de nanomedicamentos para rastreamento celular na clínica médica. Conclusões: A utilização das nanopartículas necessita a elaboração e aprovação de leis, guias e normas que orientem a indústria, como outros setores, sobre a caracterização dos nanomateriais e potenciais riscos à saúde humana, animal e ao meio ambiente.Instituto Nacional de Controle de Qualidade em Saúde2018-02-28info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion"Peer-reviewed article""Artículo revisado por pares""Artigo avaliado pelos pares"application/pdfapplication/pdfhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/106710.22239/2317-269X.01067Health Surveillance under Debate: Society, Science & Technology ; Vol. 6 No. 1 (2018): February - Tecnologias celulares avançadas: desafios biotecnológicos e regulatórios; 56-63Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; Vol. 6 Núm. 1 (2018): Febrero - Tecnologias celulares avançadas: desafios biotecnológicos e regulatórios; 56-63Vigil Sanit Debate, Rio de Janeiro; v. 6 n. 1 (2018): Fevereiro - Tecnologias celulares avançadas: desafios biotecnológicos e regulatórios; 56-632317-269Xreponame:Vigilância Sanitária em Debateinstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZporenghttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1067/429https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1067/557Copyright (c) 2018 Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia (Health Surveillance under Debate: Society, Science & Technology) – Visa em Debatehttps://creativecommons.org/licenses/by-nc-nd/4.0info:eu-repo/semantics/openAccessJasmin, .Borojevic, Radovan2023-06-27T15:07:41Zoai:ojs.visaemdebate.incqs.fiocruz.br:article/1067Revistahttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebatePUBhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/oaiincqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br2317-269X2317-269Xopendoar:2023-06-27T15:07:41Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.none.fl_str_mv |
Use of nanoparticles in cell tracing in advanced therapies: possibilities and challenges for clinical application Uso de nanopartículas no rastreamento de células em terapias avançadas: possibilidades e desafios para a aplicação clínica |
title |
Use of nanoparticles in cell tracing in advanced therapies: possibilities and challenges for clinical application |
spellingShingle |
Use of nanoparticles in cell tracing in advanced therapies: possibilities and challenges for clinical application Jasmin, . Magnetic Nanoparticles Cell Tacking Stem Cells Advanced Therapies Nanomedicine Nanopartículas Magnéticas Rastreamento Celular Células-tronco Terapias Avançadas Nanomedicamentos |
title_short |
Use of nanoparticles in cell tracing in advanced therapies: possibilities and challenges for clinical application |
title_full |
Use of nanoparticles in cell tracing in advanced therapies: possibilities and challenges for clinical application |
title_fullStr |
Use of nanoparticles in cell tracing in advanced therapies: possibilities and challenges for clinical application |
title_full_unstemmed |
Use of nanoparticles in cell tracing in advanced therapies: possibilities and challenges for clinical application |
title_sort |
Use of nanoparticles in cell tracing in advanced therapies: possibilities and challenges for clinical application |
author |
Jasmin, . |
author_facet |
Jasmin, . Borojevic, Radovan |
author_role |
author |
author2 |
Borojevic, Radovan |
author2_role |
author |
dc.contributor.author.fl_str_mv |
Jasmin, . Borojevic, Radovan |
dc.subject.por.fl_str_mv |
Magnetic Nanoparticles Cell Tacking Stem Cells Advanced Therapies Nanomedicine Nanopartículas Magnéticas Rastreamento Celular Células-tronco Terapias Avançadas Nanomedicamentos |
topic |
Magnetic Nanoparticles Cell Tacking Stem Cells Advanced Therapies Nanomedicine Nanopartículas Magnéticas Rastreamento Celular Células-tronco Terapias Avançadas Nanomedicamentos |
description |
Introduction: Regulation and introduction of new advanced cellular technologies in clinics requires better knowledge on the used cells. One of the major challenges is the difficulty to accurately determine the mechanisms of cell activities when submitted to advanced therapies. Objective: Understand, using the cell tracking methods, the tissue distribution and the molecular response of cells exposed to advanced therapies. Methods: This work was done as an integrated review of data collected in international data-bases and of legislations concerning the clinical use of nanoparticles. Results: Nanotechnology is a very useful tool for cell tracking in vivo, and several nanoparticles have been already approved for clinical use; they can be incorporated into cells and visualized by magnetic resonance imaging. Conclusions: The perspectives on the use of nanomedicines for cellular tracking in medical clinic are promising, requiring elaboration and approval of laws, guides and norms to orient the industrial sectors, regarding the nanomaterials characterization and potential risks to human and animal health, as well as to the environment. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018-02-28 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion "Peer-reviewed article" "Artículo revisado por pares" "Artigo avaliado pelos pares" |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1067 10.22239/2317-269X.01067 |
url |
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1067 |
identifier_str_mv |
10.22239/2317-269X.01067 |
dc.language.iso.fl_str_mv |
por eng |
language |
por eng |
dc.relation.none.fl_str_mv |
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1067/429 https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1067/557 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by-nc-nd/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-nd/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Instituto Nacional de Controle de Qualidade em Saúde |
publisher.none.fl_str_mv |
Instituto Nacional de Controle de Qualidade em Saúde |
dc.source.none.fl_str_mv |
Health Surveillance under Debate: Society, Science & Technology ; Vol. 6 No. 1 (2018): February - Tecnologias celulares avançadas: desafios biotecnológicos e regulatórios; 56-63 Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; Vol. 6 Núm. 1 (2018): Febrero - Tecnologias celulares avançadas: desafios biotecnológicos e regulatórios; 56-63 Vigil Sanit Debate, Rio de Janeiro; v. 6 n. 1 (2018): Fevereiro - Tecnologias celulares avançadas: desafios biotecnológicos e regulatórios; 56-63 2317-269X reponame:Vigilância Sanitária em Debate instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Vigilância Sanitária em Debate |
collection |
Vigilância Sanitária em Debate |
repository.name.fl_str_mv |
Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
incqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br |
_version_ |
1797042045212164096 |